Clear cell cancer of the ovary.

Abstract:

PURPOSE OF REVIEW:Recent discoveries have demonstrated that ovarian cancer is actually composed of multiple separate diseases. Clear cell cancer is an important example. This review will describe the unique biology of clear cell carcinoma, its novel molecular features, and the recent translation of this into new therapeutic approaches. RECENT FINDINGS:Clear cell cancer of the ovary is now recognized as a unique disease. Recent work has shown that a subset of clear cell cancers evolve from endometriosis. The oxidative stress conditions found within endometriotic lesions are likely to contribute to the transformation process. Molecular alterations within clear cell cancers include unique cytokine expression patterns and c-met amplification. Clear cell-specific clinical trials based upon these biologic discoveries have been designed and are presently active. SUMMARY:These studies provide substantive support for a unique clinical management of clear cell cancer of the ovary. Future research will exploit the molecular pathways identified in these tumors in an effort to provide more effective therapies. Presently, agents that target angiogenesis or cellular metabolism would be reasonable therapeutic approaches to these tumors.

journal_name

Curr Opin Oncol

authors

Penson RT,Dizon DS,Birrer MJ

doi

10.1097/CCO.0b013e328363e0c7

subject

Has Abstract

pub_date

2013-09-01 00:00:00

pages

553-7

issue

5

eissn

1040-8746

issn

1531-703X

pii

00001622-201309000-00016

journal_volume

25

pub_type

杂志文章,评审
  • Maintenance therapy in follicular lymphoma.

    abstract:PURPOSE OF REVIEW:This article reviews the potential benefit of maintenance therapy for patients with follicular lymphoma. RECENT FINDINGS:Follicular lymphoma, despite substantial improvements in survival, is usually incurable. Several randomized studies have shown that the combination of anti-CD20 and chemotherapy ca...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e3283490515

    authors: Michallet AS,Coiffier B,Salles G

    更新日期:2011-09-01 00:00:00

  • Interactions between the tumor suppressor p53 and immune responses.

    abstract:PURPOSE OF REVIEW:The p53 tumor suppressor is a master regulator of antitumor defenses through its control of growth arrest, senescence and apoptosis. In recent years, p53 regulation was found to extend to a variety of biological processes including autophagy, fertility, metabolism and immune responses. Here, we focus ...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e32835b6386

    authors: Menendez D,Shatz M,Resnick MA

    更新日期:2013-01-01 00:00:00

  • Biologic agents as modifiers of chemotherapeutic effects.

    abstract::Recent papers dealing with the effect of biologic response modifiers on the therapeutic activity of anticancer drugs are reviewed. Preclinical findings indicate that both interferons and tumor necrosis factor-alpha are able to synergize with different cytotoxic drugs in increasing both tumor cytotoxicity or cytostasis...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199112000-00017

    authors: Parmiani G,Rivoltini L

    更新日期:1991-12-01 00:00:00

  • What is new in the management of salivary gland cancers?

    abstract:PURPOSE OF REVIEW:Salivary gland malignancies are a rare and heterogeneous group of tumors with considerable variability in their natural history. Historically they have been treated with surgery and radiation therapy. It is only recently that there has been any growth in our understanding of these diseases and their m...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e328344f59c

    authors: Adelstein DJ,Rodriguez CP

    更新日期:2011-05-01 00:00:00

  • Critical care management of cancer patients: cause for optimism and need for objectivity.

    abstract:PURPOSE OF REVIEW:In the 1990s, cancer patients were described as poor candidates for ICU admission on the basis of high mortality rates and management costs. Over the last decade, however, advances in the management of malignancies and organ failures have led to substantial increases in survival. This review discusses...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e32832b68b6

    authors: Darmon M,Azoulay E

    更新日期:2009-07-01 00:00:00

  • Update on the pathogenesis and treatment of Kaposi sarcoma.

    abstract::Kaposi sarcoma (KS), an unusual tumor of vascular origin, was one of the first recognized manifestations of AIDS. In the past few years, it has become clear that human herpesvirus-8 (HHV-8) is critical to the development of KS in the setting of immunosuppression, such as that seen with HIV infection. Other genetic and...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-200003000-00013

    authors: Mitsuyasu RT

    更新日期:2000-03-01 00:00:00

  • Recent advances in systemic therapy for breast cancer.

    abstract::During the past year there have been a number of important advances in the area of systemic therapy for breast cancer. Combined chemoendocrine therapy has been shown to be more effective than tamoxifen alone in the adjuvant therapy of node-negative estrogen receptor-positive breast cancer. Preliminary results of a ran...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199811000-00007

    authors: Dees EC,Kennedy MJ

    更新日期:1998-11-01 00:00:00

  • Bevacizumab in the treatment of metastatic breast cancer: three case reports.

    abstract::Case reports are presented for three patients with metastatic breast cancer who received first-line treatment with bevacizumab in combination with taxanes in clinical trials. Two patients showed peak reductions in lesion size of 49 and 70%, respectively. In one patient, subsequent treatment with bevacizumab in combina...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章

    doi:10.1097/01.cco.0000397418.52374.28

    authors: Ferreira A,Vieira C,Rodrigues A,Pereira D,Rodrigues H,Dávila C,Bento S

    更新日期:2011-04-01 00:00:00

  • Adenocarcinoma of the small bowel: changes in the landscape?

    abstract:PURPOSE OF REVIEW:Small bowel adenocarcinoma (SBA) is a rare cancer with a poor prognosis and little information to guide its management. In recent years, improved diagnostic imaging and an increase in reported experience with use of chemotherapy may alter the way we manage SBA. This review will summarize recent advanc...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e32833a86fe

    authors: Speranza G,Doroshow JH,Kummar S

    更新日期:2010-07-01 00:00:00

  • Pleural effusions.

    abstract::Pleural effusions are a common development in patients with cancer. The optimal means of control are not defined, but systemic treatment is often effective in patients with drug-sensitive tumors. Local treatments advocated in the management of malignant pleural effusions differ in the means of drainage, the length of ...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199208000-00007

    authors: Tattersall M

    更新日期:1992-08-01 00:00:00

  • Controversies in the management of germ cell tumours of the ovary.

    abstract:PURPOSE OF REVIEW:Ovarian germ cell tumours are rare, but curable at all stages of disease. This review gives an outline of the main controversies regarding the management of this disease. RECENT FINDINGS:Pelvic malignancies are very rare during pregnancy, which should avoid the need for radical surgery or termination...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/01.cco.0000239891.44031.38

    authors: Patterson DM,Rustin GJ

    更新日期:2006-09-01 00:00:00

  • Bcl-2 antisense therapy in hematologic malignancies.

    abstract:PURPOSE OF REVIEW:Overexpression of the Bcl-2 oncoprotein is noted in various malignant disorders. In patients with hematologic malignancies, increased production of the Bcl-2 oncoprotein is associated with chemotherapy resistance, aggressive clinical course, and poor survival. Bcl-2 is an important molecular target. D...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/01.cco.0000142074.67968.eb

    authors: Chanan-Khan A

    更新日期:2004-11-01 00:00:00

  • Myxoid liposarcoma and the mammalian target of rapamycin pathway.

    abstract:PURPOSE OF REVIEW:Myxoid/round cell liposarcoma (MRCL) represents about 10% of all soft-tissue sarcomas. Therapeutic options for this subgroup of tumours are limited, essentially doxorubicin-based regimens and trabectedin. Recently, the mammalian target of rapamycin (mTOR) pathway has been identified as a therapeutic t...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e32836227ac

    authors: Sanfilippo R,Dei Tos AP,Casali PG

    更新日期:2013-07-01 00:00:00

  • Advances in the biology and treatment of multiple myeloma.

    abstract::Advances in the understanding of the cellular and molecular derangements involved in the initiation and progression of multiple myeloma are beginning to be translated into novel therapeutic approaches. The myeloma stem cell has been under intense scrutiny regarding its normal B-cell counterpart. Oncogenes, tumor-suppr...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199901000-00002

    authors: Varterasian ML

    更新日期:1999-01-01 00:00:00

  • Primary liver cancers.

    abstract::A review of the recent literature about liver cancers shows the increasing role of hepatitis C as a risk factor for the development of hepatocellular carcinoma. A new discussion has arisen with regard to the association between the use of oral contraceptives and hepatocellular carcinoma. Patients at risk for developin...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199507000-00017

    authors: Weimann A,Oldhafer KJ,Pichlmayr R

    更新日期:1995-07-01 00:00:00

  • Current progress in the gene therapy of cancer.

    abstract::Gene transfer for the treatment of cancer is a rapidly expanding field. Recent studies can be divided into four main areas: 1) transfer of suicide genes that convert inactive prodrugs into cytotoxic compounds, 2) transfer of genes encoding cytokines and stimulatory markers to enhance immunogenicity against tumors, 3) ...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199611000-00010

    authors: Davis BM,Koc ON,Lee K,Gerson SL

    更新日期:1996-11-01 00:00:00

  • Implications of the sentinel lymph node procedure for local and systemic adjuvant treatment.

    abstract:PURPOSE OF REVIEW:The objective of the sentinel lymph node procedure in breast cancer is to perform an accurate axillary staging and provide good local control, while sparing the patients the morbidity of an axillary lymph node dissection. Since its routine clinical use, questions were raised concerning the implication...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/01.cco.0000183542.63675.66

    authors: Smeets A,Christiaens MR

    更新日期:2005-11-01 00:00:00

  • Targeted therapy for malignant melanoma.

    abstract::Malignant melanoma is a tumor that offers unique possibilities for approaches to targeted therapy by virtue of the pigment biosynthesis pathway. Such approaches may seek to use the incorporation of toxic intermediates or to use the natural transcriptional control of genes coding for enzymes involved in melanin formati...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199403000-00016

    authors: Hart IR,Vile RG

    更新日期:1994-03-01 00:00:00

  • Atypical lipomatous tumor: molecular characterization.

    abstract:PURPOSE OF REVIEW:Atypical lipomatous tumors/well-differentiated liposarcomas (ALT/WDLs) are one of the more frequent mesenchymal neoplasms and are characterized by specific chromosome aberrations: supernumerary chromosome or giant marker chromosome or both. Extra copies of known oncogenes such as MDM2, CDK4, SAS, HMGA...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/01.cco.0000127878.85125.53

    authors: Arrigoni G,Doglioni C

    更新日期:2004-07-01 00:00:00

  • Etiology, epidemiology, risk and prognostic factors, screening, and imaging of gynecologic cancers.

    abstract::This review presents some of the articles published over the past year pertaining to the etiology, epidemiology, risk and prognostic factors, screening, and imaging techniques of gynecologic cancer. The most significant advances in this period were made in the area of the genetics of gynecologic cancers and the factor...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199309000-00016

    authors: Leung Y,DePetrillo AD

    更新日期:1993-09-01 00:00:00

  • Management of adult acute lymphoblastic leukemia: moving toward a risk-adapted approach.

    abstract::The vast majority of adults with acute lymphoblastic leukemia (ALL) now achieve remission with current intensive chemotherapy regimens. Nevertheless, most adults with ALL will eventually relapse and die of their disease. Specific clinical and molecular-cytogenetic prognostic factors have been identified that are begin...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-200101000-00004

    authors: Verma A,Stock W

    更新日期:2001-01-01 00:00:00

  • Prophylaxis and treatment of dermatologic adverse events from epidermal growth factor receptor inhibitors.

    abstract:PURPOSE OF REVIEW:As the number and uses for targeted therapies such as epidermal growth factor receptor inhibitors (EGFRIs) increase, so does the need to recognize and treat the dermatologic side-effects of these agents. Although agents such as gefitinib, erlotinib, cetuximab, lapatinib, and panitumumab have less syst...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e3283474063

    authors: Wu PA,Balagula Y,Lacouture ME,Anadkat MJ

    更新日期:2011-07-01 00:00:00

  • Imaging and response criteria in gliomas.

    abstract:PURPOSE OF REVIEW:To highlight the most recent advances in the imaging of gliomas with a focus on high-grade gliomas. In the last several years, MRI and PET imaging of the brain have moved beyond anatomic imaging and are now capable of probing different aspects of tumor biology and response to treatment. These new tech...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e32833de96e

    authors: Gerstner ER,Batchelor TT

    更新日期:2010-11-01 00:00:00

  • Somatic mutations in cancer prognosis and prediction: lessons from TP53 and EGFR genes.

    abstract:PURPOSE OF REVIEW:We used two examples of genes, TP53 and EGFR, which are somatically altered by intragenic mutations in common cancer types to illustrate how somatic mutations have followed very different routes to clinical applications. RECENT FINDINGS:TP53 somatic mutations are frequent in many cancers. Their progn...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e3283412dfa

    authors: Olivier M,Taniere P

    更新日期:2011-01-01 00:00:00

  • Reirradiation: a potentially curative approach to locally or regionally recurrent head and neck cancer.

    abstract::The treatment options for patients with recurrent head and neck malignancies arising in a previously irradiated field are limited. Surgical salvage is feasible in a minority of patients. The majority are referred for palliative chemotherapy with no realistic chance for cure. Data are accumulating to support reirradiat...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-200205000-00013

    authors: Garofalo MC,Haraf DJ

    更新日期:2002-05-01 00:00:00

  • Are we making progress in antifungal therapy?

    abstract::Contrary to the case with bacterial infections, progress in the diagnosis and treatment of invasive mycoses in cancer patients has been unsatisfactory. Amphotericin B deoxycholate has remained the drug of choice for severe invasive fungal infections for nearly 40 years. However, its infusion-related side effects, as w...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199709040-00002

    authors: Martino P,Girmenia C

    更新日期:1997-07-01 00:00:00

  • Osteosarcoma and other bone cancers.

    abstract::In this review, recent advances in the clinical therapy of osteosarcoma, including results from the European Osteosarcoma Intergroup trial demonstrating the efficacy of a short intensive two drug protocol are discussed as well the evolving role of ifosfamide. Biologically, the area of interest on chromosome 3q, which ...

    journal_title:Current opinion in oncology

    pub_type: 临床试验,杂志文章,评审

    doi:10.1097/00001622-199807000-00009

    authors: Himelstein BP

    更新日期:1998-07-01 00:00:00

  • Advances in prostate cancer.

    abstract:PURPOSE OF REVIEW:The purpose of this review is to highlight the most important developments in the diagnosis, prevention, and management of prostate cancer reported in the past year that have been published in the medical literature. RECENT FINDINGS:Recent research has yielded important insights into the effects of l...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-200405000-00009

    authors: Ryan CJ,Small EJ

    更新日期:2004-05-01 00:00:00

  • Isocitrate dehydrogenase mutations in chondrosarcoma: the crossroads between cellular metabolism and oncogenesis.

    abstract:PURPOSE OF REVIEW:This article reviews the most recent developments and implications in regard to isocitrate dehydrogenase mutations in chondrosarcoma, a disease in which currently available systemic therapies have proven inefficacious, with an emphasis on how disruption in normal cellular metabolism plays a role in on...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000092

    authors: Azzi G,Velez M,Mathias-Machado MC

    更新日期:2014-07-01 00:00:00

  • Reappraisal of eligibility criteria in cancer clinical trials.

    abstract:PURPOSE OF REVIEW:We aimed to summarize the recent reflections and collaborative initiatives pertaining to the definition of more appropriate eligibility criteria in cancer clinical trials. RECENT FINDINGS:There is an intrinsic tension between two opposite purposes when it comes to defining eligibility criteria: on th...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000470

    authors: Penel N,Lebellec L,Vanseymortier M

    更新日期:2018-09-01 00:00:00